Case Report: GNAQ- and SF3B1 Mutations in an Aggressive Case of Relapsing Uveal Ring Melanoma

Michelle Prasuhn1, Josephine Christin Freitag1, Sabine Lüken1

  • 1Department of Ophthalmology, University Hospital Schleswig-Holstein, University of Lübeck, Lübeck, Germany.

Frontiers in Oncology
|June 13, 2022
PubMed

Insights

Uveal ring melanoma molecular mechanisms remain unknown. This case report identifies novel GNAQ and SF3B1 mutations in a recurrent uveal melanoma, offering new genetic insights into this ocular tumor.

Area of Science:

  • Ophthalmology
  • Oncology
  • Molecular Genetics

Background:

  • Uveal melanoma is the most common primary intraocular malignancy.
  • The molecular underpinnings of uveal ring melanoma, a rare variant, are not well understood.
  • Understanding genetic mutations is crucial for targeted therapies and improved prognoses.

Observation:

  • A patient with malignant uveal melanoma and exudative retinal detachment was treated with plaque brachytherapy.
  • A ring-shaped recurrence with extraocular extension developed one year post-treatment, necessitating enucleation.
  • Histological analysis confirmed epithelioid-cell-type melanoma involving the ciliary body.

Findings:

  • Novel GNAQ and SF3B1 mutations were identified in the recurrent uveal ring melanoma.
  • These mutations represent a previously unreported genetic profile for this specific tumor presentation.
  • The findings provide new genetic background information on uveal ring melanoma.

Implications:

  • The identified mutations may play a role in the pathogenesis and recurrence of uveal ring melanoma.
  • This genetic information could potentially inform future diagnostic and therapeutic strategies.
  • Further research into these mutations may improve understanding and management of this ocular tumor.

Related Concept Videos